Less is more? STI in acute and chronic HIV-1 infection

被引：40

作者：

Altfeld, M ^{[1
]}

Walker, BD

机构：

[1] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

NATURE MEDICINE | 2001年 / 7卷 / 08期

关键词：

D O I：

10.1038/90901

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Emerging data has indicated that supervised treatment interruption (STI) of highly active antiretroviral therapy might significantly augment immune responses in HIV-1-infected patients and slow disease progression. Here the authors discuss the rationale behind STI and future directions for study.

引用

页码：881 / 884

页数：4

共 54 条

[21] Harrer T, 1996, J IMMUNOL, V156, P2616
[22] Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
Hatano, H
Vogel, S
Yoder, C
Metcalf, JA
Dewar, R
Davey, RT
Polis, MA
[J]. AIDS, 2000, 14 (10) : 1357 - 1363
[23] Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Hel, Z
Venzon, D
Poudyal, M
Tsai, WP
Giuliani, L
Woodward, R
Chougnet, C
Shearer, G
Altman, JD
Watkins, D
Bischofberger, N
Abimiku, A
Markham, P
Tartaglia, J
Franchini, G
[J]. NATURE MEDICINE, 2000, 6 (10) : 1140 - 1146
[24] HERMANS P, 2001, 8 C RETR OPP INF CHI
[25] Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques
Jin, X
Bauer, DE
Tuttleton, SE
Lewin, S
Gettie, A
Blanchard, J
Irwin, CE
Safrit, JT
Mittler, J
Weinberger, L
Kostrikis, LG
Zhang, LQ
Perelson, AS
Ho, DD
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) : 991 - 998
[26] Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
Kalams, SA
Buchbinder, SP
Rosenberg, ES
Billingsley, JM
Colbert, DS
Jones, NG
Shea, AK
Trocha, AK
Walker, BD
[J]. JOURNAL OF VIROLOGY, 1999, 73 (08) : 6715 - 6720
[27] Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report
Kilby, JM
Goepfert, PA
Miller, AP
Gnann, JW
Sillers, M
Saag, MS
Bucy, RP
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 435 - 438
[28] Control of HIV despite the discontinuation of antiretroviral therapy
Lisziewicz, J
Rosenberg, E
Lieberman, J
Jessen, H
Lopalco, L
Siliciano, R
Walker, B
Lori, F
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) : 1683 - 1684
[29] Control of SIV rebound through structured treatment interruptions during early infection
Lori, F
Lewis, MG
Xu, JQ
Varga, G
Zinn, DE
Crabbs, C
Wagner, W
Greenhouse, J
Silvera, P
Yalley-Ogunro, J
Tinelli, C
Lisziewicz, J
[J]. SCIENCE, 2000, 290 (5496) : 1591 - 1593
[30] Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters
Lori, F
Rosenberg, E
Lieberman, J
Foli, A
Maserati, R
Seminari, E
Alberici, F
Walker, B
Lisziewicz, J
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (15) : 1333 - 1338

← 1 2 3 4 5 6 →